<!DOCTYPE html>
<!--
==============================================================================
           "GitHub HTML5 Pandoc Template" v2.1 — by Tristano Ajmone           
==============================================================================
Copyright © Tristano Ajmone, 2017, MIT License (MIT). Project's home:

- https://github.com/tajmone/pandoc-goodies

The CSS in this template reuses source code taken from the following projects:

- GitHub Markdown CSS: Copyright © Sindre Sorhus, MIT License (MIT):
  https://github.com/sindresorhus/github-markdown-css

- Primer CSS: Copyright © 2016-2017 GitHub Inc., MIT License (MIT):
  http://primercss.io/

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
The MIT License 

Copyright (c) Tristano Ajmone, 2017 (github.com/tajmone/pandoc-goodies)
Copyright (c) Sindre Sorhus <sindresorhus@gmail.com> (sindresorhus.com)
Copyright (c) 2017 GitHub Inc.

"GitHub Pandoc HTML5 Template" is Copyright (c) Tristano Ajmone, 2017, released
under the MIT License (MIT); it contains readaptations of substantial portions
of the following third party softwares:

(1) "GitHub Markdown CSS", Copyright (c) Sindre Sorhus, MIT License (MIT).
(2) "Primer CSS", Copyright (c) 2016 GitHub Inc., MIT License (MIT).

Permission is hereby granted, free of charge, to any person obtaining a copy
of this software and associated documentation files (the "Software"), to deal
in the Software without restriction, including without limitation the rights
to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
copies of the Software, and to permit persons to whom the Software is
furnished to do so, subject to the following conditions:

The above copyright notice and this permission notice shall be included in all
copies or substantial portions of the Software.

THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
SOFTWARE.
==============================================================================-->
<html>
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <title>Sickle cell disease MeG-CLS-076</title>
  <style type="text/css">
@charset "UTF-8";.markdown-body{-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;color:#24292e;font-family:-apple-system,system-ui,BlinkMacSystemFont,"Segoe UI",Helvetica,Arial,sans-serif,"Apple Color Emoji","Segoe UI Emoji","Segoe UI Symbol";font-size:16px;line-height:1.5;word-wrap:break-word;box-sizing:border-box;min-width:200px;max-width:980px;margin:0 auto;padding:45px}.markdown-body a{color:#0366d6;background-color:transparent;text-decoration:none;-webkit-text-decoration-skip:objects}.markdown-body a:active,.markdown-body a:hover{outline-width:0}.markdown-body a:hover{text-decoration:underline}.markdown-body a:not([href]){color:inherit;text-decoration:none}.markdown-body strong{font-weight:600}.markdown-body h1,.markdown-body h2,.markdown-body h3,.markdown-body h4,.markdown-body h5,.markdown-body h6{margin-top:24px;margin-bottom:16px;font-weight:600;line-height:1.25}.markdown-body h1{font-size:2em;margin:.67em 0;padding-bottom:.3em;border-bottom:1px solid #eaecef}.markdown-body h2{padding-bottom:.3em;font-size:1.5em;border-bottom:1px solid #eaecef}.markdown-body h3{font-size:1.25em}.markdown-body h4{font-size:1em}.markdown-body h5{font-size:.875em}.markdown-body h6{font-size:.85em;color:#6a737d}.markdown-body img{border-style:none}.markdown-body svg:not(:root){overflow:hidden}.markdown-body hr{box-sizing:content-box;height:.25em;margin:24px 0;padding:0;overflow:hidden;background-color:#e1e4e8;border:0}.markdown-body hr::before{display:table;content:""}.markdown-body hr::after{display:table;clear:both;content:""}.markdown-body input{margin:0;overflow:visible;font:inherit;font-family:inherit;font-size:inherit;line-height:inherit}.markdown-body [type=checkbox]{box-sizing:border-box;padding:0}.markdown-body *{box-sizing:border-box}.markdown-body blockquote{margin:0}.markdown-body ol,.markdown-body ul{padding-left:2em}.markdown-body ol ol,.markdown-body ul ol{list-style-type:lower-roman}.markdown-body ol ol,.markdown-body ol ul,.markdown-body ul ol,.markdown-body ul ul{margin-top:0;margin-bottom:0}.markdown-body ol ol ol,.markdown-body ol ul ol,.markdown-body ul ol ol,.markdown-body ul ul ol{list-style-type:lower-alpha}.markdown-body li>p{margin-top:16px}.markdown-body li+li{margin-top:.25em}.markdown-body dd{margin-left:0}.markdown-body dl{padding:0}.markdown-body dl dt{padding:0;margin-top:16px;font-size:1em;font-style:italic;font-weight:600}.markdown-body dl dd{padding:0 16px;margin-bottom:16px}.markdown-body code{font-family:SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace}.markdown-body pre{font:12px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;word-wrap:normal}.markdown-body blockquote,.markdown-body dl,.markdown-body ol,.markdown-body p,.markdown-body pre,.markdown-body table,.markdown-body ul{margin-top:0;margin-bottom:16px}.markdown-body blockquote{padding:0 1em;color:#6a737d;border-left:.25em solid #dfe2e5}.markdown-body blockquote>:first-child{margin-top:0}.markdown-body blockquote>:last-child{margin-bottom:0}.markdown-body table{display:block;width:100%;overflow:auto;border-spacing:0;border-collapse:collapse}.markdown-body table th{font-weight:600}.markdown-body table td,.markdown-body table th{padding:6px 13px;border:1px solid #dfe2e5}.markdown-body table tr{background-color:#fff;border-top:1px solid #c6cbd1}.markdown-body table tr:nth-child(2n){background-color:#f6f8fa}.markdown-body img{max-width:100%;box-sizing:content-box;background-color:#fff}.markdown-body code{padding:.2em 0;margin:0;font-size:85%;background-color:rgba(27,31,35,.05);border-radius:3px}.markdown-body code::after,.markdown-body code::before{letter-spacing:-.2em;content:" "}.markdown-body pre>code{padding:0;margin:0;font-size:100%;word-break:normal;white-space:pre;background:0 0;border:0}.markdown-body .highlight{margin-bottom:16px}.markdown-body .highlight pre{margin-bottom:0;word-break:normal}.markdown-body .highlight pre,.markdown-body pre{padding:16px;overflow:auto;font-size:85%;line-height:1.45;background-color:#f6f8fa;border-radius:3px}.markdown-body pre code{display:inline;max-width:auto;padding:0;margin:0;overflow:visible;line-height:inherit;word-wrap:normal;background-color:transparent;border:0}.markdown-body pre code::after,.markdown-body pre code::before{content:normal}.markdown-body .full-commit .btn-outline:not(:disabled):hover{color:#005cc5;border-color:#005cc5}.markdown-body kbd{box-shadow:inset 0 -1px 0 #959da5;display:inline-block;padding:3px 5px;font:11px/10px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;color:#444d56;vertical-align:middle;background-color:#fcfcfc;border:1px solid #c6cbd1;border-bottom-color:#959da5;border-radius:3px;box-shadow:inset 0 -1px 0 #959da5}.markdown-body :checked+.radio-label{position:relative;z-index:1;border-color:#0366d6}.markdown-body .task-list-item{list-style-type:none}.markdown-body .task-list-item+.task-list-item{margin-top:3px}.markdown-body .task-list-item input{margin:0 .2em .25em -1.6em;vertical-align:middle}.markdown-body::before{display:table;content:""}.markdown-body::after{display:table;clear:both;content:""}.markdown-body>:first-child{margin-top:0!important}.markdown-body>:last-child{margin-bottom:0!important}.Alert,.Error,.Note,.Success,.Warning{padding:11px;margin-bottom:24px;border-style:solid;border-width:1px;border-radius:4px}.Alert p,.Error p,.Note p,.Success p,.Warning p{margin-top:0}.Alert p:last-child,.Error p:last-child,.Note p:last-child,.Success p:last-child,.Warning p:last-child{margin-bottom:0}.Alert{color:#246;background-color:#e2eef9;border-color:#bac6d3}.Warning{color:#4c4a42;background-color:#fff9ea;border-color:#dfd8c2}.Error{color:#911;background-color:#fcdede;border-color:#d2b2b2}.Success{color:#22662c;background-color:#e2f9e5;border-color:#bad3be}.Note{color:#2f363d;background-color:#f6f8fa;border-color:#d5d8da}.Alert h1,.Alert h2,.Alert h3,.Alert h4,.Alert h5,.Alert h6{color:#246;margin-bottom:0}.Warning h1,.Warning h2,.Warning h3,.Warning h4,.Warning h5,.Warning h6{color:#4c4a42;margin-bottom:0}.Error h1,.Error h2,.Error h3,.Error h4,.Error h5,.Error h6{color:#911;margin-bottom:0}.Success h1,.Success h2,.Success h3,.Success h4,.Success h5,.Success h6{color:#22662c;margin-bottom:0}.Note h1,.Note h2,.Note h3,.Note h4,.Note h5,.Note h6{color:#2f363d;margin-bottom:0}.Alert h1:first-child,.Alert h2:first-child,.Alert h3:first-child,.Alert h4:first-child,.Alert h5:first-child,.Alert h6:first-child,.Error h1:first-child,.Error h2:first-child,.Error h3:first-child,.Error h4:first-child,.Error h5:first-child,.Error h6:first-child,.Note h1:first-child,.Note h2:first-child,.Note h3:first-child,.Note h4:first-child,.Note h5:first-child,.Note h6:first-child,.Success h1:first-child,.Success h2:first-child,.Success h3:first-child,.Success h4:first-child,.Success h5:first-child,.Success h6:first-child,.Warning h1:first-child,.Warning h2:first-child,.Warning h3:first-child,.Warning h4:first-child,.Warning h5:first-child,.Warning h6:first-child{margin-top:0}h1.title,p.subtitle{text-align:center}h1.title.followed-by-subtitle{margin-bottom:0}p.subtitle{font-size:1.5em;font-weight:600;line-height:1.25;margin-top:0;margin-bottom:16px;padding-bottom:.3em}div.line-block{white-space:pre-line}
  </style>
  <style type="text/css">code{white-space: pre;}</style>
  <!--[if lt IE 9]>
    <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.7.3/html5shiv-printshiv.min.js"></script>
  <![endif]-->
</head>
<body>
<article class="markdown-body">
<h1 id="sickle-cell-disorders">Sickle cell disorders</h1>
<h2 id="executive-summary"><em>Executive summary</em></h2>
<h2 id="introduction">Introduction</h2>
<p>Haemoglobin (Hb) is a tetrameric protein composed of four subunits. In the foetus, the predominant Hb is HbF (which has 2 alpha and 2 gamma subunits). This is replaced in the postnatal period by HbA (which has 2 alpha and 2 beta subunits) and HbA2 (2 alpha and 2 delta subunits).</p>
<p>In sickle cell disease, an individual inherits 2 abnormal beta subunits, at least one of which is HbS. This produces red blood cells which are prone to sickling and cause a range of symptoms and pathology.</p>
<p>The common sickle cell syndromes are: HbSS disease, HbSC disease, HbS-beta thalassaemia and other rare variants. The inheritance of SS disease follows simple Mendelian principles.</p>
<h2 id="target-users">Target users</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Doctors</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Nurses</p>
</div></li>
</ul>
<h2 id="target-area-of-use">Target area of use </h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Ward</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Outpatient department</p>
</div></li>
</ul>
<h2 id="key-areas-of-focus-new-additions-changes">Key areas of focus / New additions / Changes </h2>
<p>This guideline outlines the initial diagnosis and management of sickle cell disease and its complications.</p>
<h2 id="limitations">Limitations</h2>
<p>Exchange transfusion and modern preventative treatments such as hydroxyurea are not available in the Gambia.</p>
<h2 id="presenting-symptoms-and-signs">Presenting symptoms and signs</h2>
<p>The most common signs and symptoms are linked to anaemia. As a result, they may feel tired or weak. Fatigue is one of the most common symptoms of sickle cell anaemia.</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Non-specific symptoms:</p>
</div>
<ul>
<li><div data-custom-style="List Paragraph">
<blockquote>
<p>Fatigue</p>
</blockquote>
</div></li>
<li><div data-custom-style="List Paragraph">
<blockquote>
<p>Headaches</p>
</blockquote>
</div></li>
<li><div data-custom-style="List Paragraph">
<blockquote>
<p>Dizziness</p>
</blockquote>
</div></li>
<li><div data-custom-style="List Paragraph">
<blockquote>
<p>Fever</p>
</blockquote>
</div></li>
</ul></li>
<li><div data-custom-style="List Paragraph">
<p>Pain in any part of the body</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Symptoms of specific syndromes:</p>
</div></li>
</ul>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Shortness of breath</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Cough</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Abdominal distension</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Swelling of the hands or feet</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Leg ulcers</p>
</div></li>
</ul>
<h2 id="examination-findings">Examination findings</h2>
<p>The early signs include: pallor, jaundice, hepato-splenomegaly (signs of visceral sequestration) and hand-foot syndrome (dactylitis).</p>
<p>Signs consistent with important complications include:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<blockquote>
<p>Tachycardia, tachypnoea and hypotension (signs of sepsis)</p>
</blockquote>
</div></li>
<li><div data-custom-style="List Paragraph">
<blockquote>
<p>Signs of heart failure and murmur due to anaemia</p>
</blockquote>
</div></li>
<li><div data-custom-style="List Paragraph">
<blockquote>
<p>Respiratory distress (acute chest syndrome)</p>
</blockquote>
</div></li>
<li><div data-custom-style="List Paragraph">
<blockquote>
<p>Bone pain consistent with vaso-occlusive crisis or osteomyelitis</p>
</blockquote>
</div></li>
<li><div data-custom-style="List Paragraph">
<blockquote>
<p>Priapism</p>
</blockquote>
</div></li>
<li><div data-custom-style="List Paragraph">
<blockquote>
<p>Haematuria</p>
</blockquote>
</div></li>
<li><div data-custom-style="List Paragraph">
<blockquote>
<p>Evidence of stroke</p>
</blockquote>
</div></li>
</ul>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Leg ulcers</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Frontal bossing and protrusion of upper teeth (gnathopathy)</p>
</div></li>
</ul>
<h2 id="differential-diagnoses">Differential diagnoses</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Rheumatic fever</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Rheumatoid arthritis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Osteomyelitis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Leukaemia</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Splenic abscess</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Hepatitis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Ischaemic colitis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Peptic ulcer.</p>
</div></li>
</ul>
<h2 id="investigations">Investigations</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Blood Tests:</p>
</div>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Hb genotype (sickle test has very low specificity and sensitivity and is not useful)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>FBC &amp; reticulocytes( Reduced Hb, elevated WCC, elevated Platelets, increased retics)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Group and save</p>
</div></li>
</ul></li>
<li><div data-custom-style="List Paragraph">
<p>Blood film or RDT for malaria parasites (sickled cells, poikilocytes and target cells)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Microbiological screen: Urine dipstick &amp; culture, blood culture</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Radiology:</p>
</div>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Chest x-ray if indicated (i.e. symptoms/signs)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>X-ray of the hands: initially not informative but later shows evidence of destruction and repair of bones</p>
</div></li>
</ul></li>
</ul>
<h2 id="management-in-opd">Management in OPD</h2>
<h3 id="antibiotics">Antibiotics: </h3>
<p>Patients who have previously been admitted to hospital with a serious infection should be treated with prophylactic penicillin V 7.5 mg/kg up to 500 mg BD.</p>
<h3 id="folic-acid">Folic acid:</h3>
<p>From 1 month to 3 years of age, give 2.5 mg OD. Above 3 years of age give, 5 mg OD.</p>
<h3 id="anti-malarials">Anti-malarials:</h3>
<p>Patients should receive anti-malarial prophylaxis during the transmission season. This should usually be started as soon as the first rain has occurred (and not before) and should continue until the end of the calendar year. Give mefloquine (5-10 mg/kg up to 250 mg once per week).</p>
<h3 id="appointments">Appointments</h3>
<p>Children with sickle cell disease are seen 3 monthly until 2 years of age and six-monthly thereafter, unless there are medical, educational or psychosocial concerns in which case they should be seen more frequently. If patients are stable, in Fajara, they should be referred on to another health facility for ongoing care.</p>
<p>Children who have frequent crises have been shown to have better outcomes if their parents bring them for medical care sooner when they deteriorate. Teach carers about the importance of taking pain and fevers seriously. Studies have shown that parents can be taught to recognize splenomegaly, which is an indication to present to the clinic.</p>
<h2 id="management-on-the-ward">Management on the ward</h2>
<p>Management is supportive unless there are complications or indications for exchange transfusion. (This is not routinely offered and must be discussed with a consultant.)</p>
<p>General management includes:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p><strong>Reassurance that the patient’s pain will be relieved as soon as possible</strong></p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><strong>Massage and distraction techniques may help some children</strong></p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><strong>Warmth</strong></p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><strong>Establishing a position of maximum comfort</strong></p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><strong>Hyperhydration (see below)</strong></p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><strong>Oxygen supplementation when necessary</strong></p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><strong>Establish IV access as soon as possible</strong></p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><strong>Identification and treatment of infection</strong></p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><strong>Regular observations and reassessment</strong></p>
</div></li>
</ul>
<h3 id="fluids-sodium-chloride-0.9">Fluids (Sodium chloride 0.9%)</h3>
<p>Aim to give 1.5 times as much fluid as usual:</p>
<table>
<thead>
<tr class="header">
<th><strong>Body weight (kg)</strong></th>
<th><strong>Fluids (mL/kg/day)</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Up to 10 kg</td>
<td>150 mL/kg/day</td>
</tr>
<tr class="even">
<td>11 - 20 kg</td>
<td>1500 mL + 75 mL/kg/day for each kilo over 10 kg</td>
</tr>
<tr class="odd">
<td>&gt;20 kg</td>
<td>2250 mL + 30 mL/kg/day for each 1 kg body weight over 20kg</td>
</tr>
</tbody>
</table>
<h3 id="analgesia">Analgesia </h3>
<p>An analgesic ladder is used according to the severity of pain and a pain tool must always be used to monitor effectiveness of pain relief.</p>
<p>Give paracetamol (15 mg/kg up to 1 g QDS) or ibuprofen (5 mg/kg up to 400 mg TDS) as a single agent of pain relief if not already given.</p>
<p>If pain persists, give paracetamol and ibuprofen together.</p>
<p>If pain persists, continue paracetamol and ibuprofen and add:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Codeine phosphate (0.5-1.0 mg/kg up to 30 mg TDS) for rapid oral opiate pain relief.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>If injectable pain relief required: SC Morphine (begin with 0.1-0.2 mg/kg up to 2.5 mg and titrate until pain is controlled).</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>If the patient requires regular on-going opiate pain relief, Morphine Slow-release Tablets (MST) may be used in place of codeine phosphate. To find the equivalent dose, divide total daily dose of codeine by 8-10 and give half this amount as MST BD).</p>
</div></li>
</ul>
<h2 id="management-of-complications">Management of complications</h2>
<p><strong><span class="underline">Veno-occlusive crisis:</span></strong> Presents with bone or body pain. Occurs when hypoxia, infection, dehydration or pregnancy trigger sickling which causes capillary blockage. This results in local ischaemia of tissues. In infants and toddlers, it often affects the hand and feet and presents as dactylitis (which is a poor prognostic factor). If the spleen is involved, it may suddenly enlarge and is very painful. This is also a poor prognostic factor. Treatment is with pain relief and hyperhydration. If there is evidence of infection, this should be treated.</p>
<p><strong><span class="underline">Infection</span></strong>: Occurs as a complication of a veno-occlusive crisis or secondary to asplenism. Patients are at increased risk of sepsis from capsulated bacteria including <em>pneumococcus</em>, <em>haemophilus influenzae</em> and <em>salmonella</em> spp. Patients presenting with infections severe enough to require hospital admission should be treated with the usual antibiotics indicated for the suspected site of infection. The exception to this is osteomyelitis, which should be treated with chloramphenicol 25 mg/kg up to 500 mg QDS for 2 weeks. Also, ensure child is fully vaccinated as this helps with infection from some of the encapsulated bacteria listed above.</p>
<p><strong><span class="underline">Stroke:</span></strong> This is a complication of veno-occlusive crisis affecting the brain. Ten percent (10%) of sickle cell patients will have a stroke before the age of 20 years and those who have had one stroke have a 60% chance of having a second stroke. Patients with an acute stroke have a better outcome if they receive blood transfusion to keep their Hb above 10 g/dl and oxygen to keep their saturations above 95%. They should then continue to receive regular transfusions to keep their Hb at 10 g/dl. This should ideally be done by exchange transfusion, but this is not available in our setting.</p>
<p><strong><span class="underline">Acute chest syndrome:</span></strong> This is a complication of veno-occlusive crisis affecting the lungs. This is commonly associated with secondary respiratory infection. The mortality rate is 10% even in the best centres. The patient should be treated with oxygen, salbutamol nebulisers and benzyl penicillin 500,000 units/kg up to 2 megaunits QDS and chloramphenicol 25 mg/kg up to 500 mg QDS. Transfuse if the Hb is below 10 g/dl.</p>
<p><strong><span class="underline">Renal failure:</span></strong> will occur in one third of patients over their lifetime. This is due to recurrent renal ischaemia. Patients with sickle cell disease who are admitted must be adequately hydrated as above.</p>
<p><strong><span class="underline">Complications of pregnancy:</span></strong> occur when the placenta becomes ischaemic during a crisis. This presents with spontaneous abortion, placental abruption and premature labour. Pregnant sickle cell patients require specialised obstetric care. Early referral to the O&amp;G unit of EFSTH is thus necessary.</p>
<p><strong><span class="underline">Priapism:</span></strong> occurs when sickling affects the penis and is very painful. It should be treated with adequate pain relief and hyperhydration. If there is no rapid relief, blood must be aspirated from the penis with a needle. Referral to the urologist is necessary at this point.</p>
<h2 id="key-issues-for-nursing-care">Key Issues for Nursing care</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Timely assessment of patients.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Advocate for rapid and effective treatment of pain.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Develop trusting relationship with patient and family.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Educate patients to use a pro-active approach in pain management.</p>
</div></li>
</ul>
<h2 id="references">References</h2>
<p>Sickle Cell Information Center (2016) What is sickle cell disease. Retrieved from http://scinfo.org/index.php/what-is-sickle-cell-disease</p>
<p><a href="http://www.sicklecelldisease.org/"><span class="underline">http://www.sicklecelldisease.org/</span></a>:</p>
<p><a href="http://www.sicklecellsociety.org/"><span class="underline">http://www.sicklecellsociety.org/</span></a> : information, Counselling and Caring for those with Sickle Cell Disorders and their families: UK based</p>
<p>Expert Panel Report, US Department of Health and Human Services. Evidence-Based Management of Sickle Cell Disease. <em>National Institutes of Health</em>. 2014.</p>
<p>Imperial Paediatric Sickle Cell Pain Management Protocol</p>
<p>http://www.who.int/en/</p>
<p>Nelson text book of paediatrics</p>
<table>
<thead>
<tr class="header">
<th><strong>Written by:</strong></th>
<th>Name: Yorro Bah</th>
<th>Date: 22 June 2019</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Reviewed by:</strong></td>
<td>Name: Karen Forrest</td>
<td>Date: 24 July 2019</td>
</tr>
<tr class="even">
<td><strong>Version:</strong></td>
<td><strong>Change history:</strong></td>
<td><strong>Review due date:</strong></td>
</tr>
<tr class="odd">
<td>1.0</td>
<td>New document</td>
<td>30 August 2021</td>
</tr>
<tr class="even">
<td>Review Comments (<em>if applicable)</em></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</article>
</body>
</html>
